Paradigm Biocapital Advisors LP

Q1 2025 13F Holdings

  • Location
    new york, NY
  • Num holdings

    28

  • Value ($000)

    $2,183,398

  • Date Filed
    05/15/2025
  • Form type
    13F-HR
  • CIK
    0001855655
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
NUVL
NUVL

NUVALENT INC

COM
670703107
$373.71 M
17 %

5,269,433

ACLX
ACLX

ARCELLX INC

COMMON STOCK
03940C100
$294.68 M
14 %

4,492,032

RVMD
RVMD

REVOLUTION MEDICINES INC

COM
76155X100
$218.46 M
10 %

6,178,111

BGNE
BGNE

BEIGENE LTD

SPONSORED ADS
07725L102
$181.27 M
8 %

666,024

---

MERUS N V

COM
N5749R100
$141.83 M
7 %

3,369,699

TARS
TARS

TARSUS PHARMACEUTICALS INC

COM
87650L103
$134.09 M
6 %

2,610,197

EWTX
EWTX

EDGEWISE THERAPEUTICS INC

COM
28036F105
$96.68 M
4 %

4,394,556

JANX
JANX

JANUX THERAPEUTICS INC

COM
47103J105
$89.91 M
4 %

3,329,909

CRNX
CRNX

CRINETICS PHARMACEUTICALS IN

COM
22663K107
$65.27 M
3 %

1,946,168

PCVX
PCVX

VAXCYTE INC

COM
92243G108
$64.06 M
3 %

1,696,481

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 28